Uncertainty on revenue growth, margin outlook hits Gland Pharma stock ...Middle East

Business Standard - Economy
The injectable manufacturing company expects the margin pressure to persist due to cost pressures and negative operating leverage.

Hence then, the article about uncertainty on revenue growth margin outlook hits gland pharma stock was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Uncertainty on revenue growth, margin outlook hits Gland Pharma stock )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News